29 Aug 2016
Ascendis Health rights offer oversubscribed
By Staff Writer
Ascendis Health has announced that its R1.2 billion rights issue, which closed last week, has been more than three times oversubscribed. The company has also secured the required funding to conclude its recent R7.3 billion acquisitions of global pharma company, Remedica and European sports nutrition company, Scitec.
